ロード中...
Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
Docetaxel (DTX) is an effective commercial anticancer agent for chemotherapy in non–small cell lung cancer (NSCLC), breast cancer, gastric cancer, and prostate cancer, but its adverse effects including edema, neurotoxicity, and hair loss limit its application. To improve the chemotherapeutic efficac...
保存先:
| 出版年: | Integr Cancer Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739130/ https://ncbi.nlm.nih.gov/pubmed/27151585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1534735416645184 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|